Search Results - "Martin, Sherry A"

Physician perceptions of GLP-1 receptor agonists in the UK by Matza, Louis S., Curtis, Sarah E., Jordan, Jessica B., Adetunji, Omolara, Martin, Sherry A., Boye, Kristina S.

“…Objectives Glucagon-like peptide-1 (GLP-1) receptor agonists have been used to treat type 2 diabetes for almost a decade, and new treatments in this class have…”
Get full text

Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review by Jendle, Johan, Martin, Sherry A, Milicevic, Zvonko

“…Glucagon-like peptide-1 (GLP-1) receptor agonists have been used in clinical management of type 2 diabetes since 2005. Currently approved agents were initially…”
Get more information

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes by Buse, John B, Wolffenbuttel, Bruce H.R, Herman, William H, Shemonsky, Natalie K, Jiang, Honghua H, Fahrbach, Jessie L, Scism-Bacon, Jamie L, Martin, Sherry A

“…OBJECTIVE: To compare the ability of two starter insulin regimens to achieve glycemic control in a large, ethnically diverse population with type 2 diabetes…”
Get full text

DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine by Buse, John B, Wolffenbuttel, Bruce H.R, Herman, William H, Hippler, Stephen, Martin, Sherry A, Jiang, Honghua H, Shenouda, Sylvia K, Fahrbach, Jessie L

“…OBJECTIVE: This study compared the durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25: 75% insulin lispro protamine suspension/25%…”
Get full text

Association of blood glucose levels with in-hospital mortality and 30-day readmission in patients undergoing invasive cardiovascular surgery by Lee, Lauren J., Emons, Matthew F., Martin, Sherry A., Faries, Douglas, Bae, Jay, Nathanson, Brian H., Yu, Hsing-Ting, Haidar, Tracy, Bode, Bruce W.

“…Abstract Objective: This study aimed to evaluate the association of mean and maximum blood glucose (BG) levels with in-hospital mortality and 30-day hospital…”
Get full text

Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial by Lee, Lauren J, Fahrbach, Jessie L, Nelson, Lauren M, McLeod, Lori D, Martin, Sherry A, Sun, Peter, Weinstock, Ruth S

“…Abstract Aim To examine changes in patient-reported outcome (PRO) measures in patients with type 2 diabetes (T2DM) on oral agents who initiated insulin…”
Get full text

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial by Buse, John B., Wolffenbuttel, Bruce H.R., Herman, William H., Hippler, Stephen, Martin, Sherry A., Jiang, Honghua H., Shenouda, Sylvia K., Fahrbach, Jessie L.

“…OBJECTIVE This study compared the durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25: 75% insulin lispro protamine suspension/25%…”
Get full text

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results by Buse, John B., Wolffenbuttel, Bruce H.R., Herman, William H., Shemonsky, Natalie K., Jiang, Honghua H., Fahrbach, Jessie L., Scism-Bacon, Jamie L., Martin, Sherry A.

“…DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results Safety and efficacy of insulin lispro mix 75/25 versus insulin…”
Get full text

The durability of basal versus lispro mix 75/2S insulin efficacy Trial: comparing the durability of lispro mix 75/25 and glargine by Buse, John B, Wolffenbuttel, Bruce H.R, Herman, William H, Hippler, Stephen, Martin, Sherry A, Jiang, Honghua H, Shenouda, Sylvia K, Fahrbach, Jessie L

Get full text